View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United States |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2028-06-15 |
| Par Value | 2000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 600.00 |
| Coupon | 4.3 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 600.000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Edwards Lifesciences Corp corporate note has a 4.30% fixed rate coupon paid on a semi-annual basis. It was issued on June 15, 2018 with an issue size of 600.00 million USD and matures on June 15, 2028 with a last coupon date of December 15, 2027. |
Edwards Lifesciences Corp, founded in 1958 and headquartered in Irvine, California, is a global leader in providing innovative solutions for heart valve and critical care monitoring. The company specializes in transcatheter heart valves, surgical heart valves, and hemodynamic monitoring systems, aiming to enhance patient care through scientifically advanced technologies.